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Background: Complementary medicines (CMs) are widely used by women. Although, women in Australia are
frequent users of CM, few studies have examined their utilisation by women attending a family planning service.
The aim of this study was to examine (i) the extent of and type of CM, (ii) women’s views about safety and efficacy,
and (iii) the factors influencing women’s decision-making.
Methods: A cross-sectional survey using a convenience sample of 221women aged greater than 18 years
attending a family planning (FP) service was undertaken over a two week period in Sydney, Australia. An
anonymous self-administered questionnaire was designed to examine women’s current and previous use of CMs,
their attitudes towards safety and effectiveness, the factors influencing their decision-making, and their disclosure
of CM use to a FP health professional. Demographic questions were designed to describe the diversity of the
participants. Logistic regression was used to examine the association between CM use and demographics.
Results: Sixty-seven percent of women surveyed were currently using CMs, and 83% reported use during the
previous 12 months. Most respondents utilised CMs to maintain their general health or for prevention of ill health.
Over 30% of women lacked information to make an informed response to questions examining their views about
the safety of CMs. Forty-four percent of participants stated they discussed their use of CMs with their FP providers.
The main reason why women did not mention CMs was they did not see the relevance to their consultation
(43%). Lower rates of CM use were found for younger women (OR 0.24, 95% CI 0.09-0.61), and those not
completing high school (OR 0.44, 95% 0.20-1.00).
Conclusion: The use of CM is very common among women attending an Australian FP clinic, however our
findings may not be generalisable to all women. We identified a notable gap in women’s awareness of the
potential for interactions between CM and prescribed medication. Our findings also emphasise the need for
healthcare providers to initiate discussions with clients about their utilisation of CM.
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The use of CMs among women seeking reproductive
health care in clinical settings in relation to menopause
[1], infertility [2], and pregnancy [3], has been investi-
gated. A review of this literature indicates that resorting
to some form of CM for fertility enhancement varies
from 29% to 91% [2]. The Australian Longitudinal Study* Correspondence: caroline.smith@uws.edu.au
1Centre for Complementary Medicine Research, University of Western Sydney,
Penrith, Australia
Full list of author information is available at the end of the article
© 2013 Smith et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the oron Women’s Health in 2006 revealed that 81% of preg-
nant women reported the self-prescribed use of vitamins
and minerals, 33% consulted with a CM practitioner,
and 19% consumed herbal medicines [3], and nearly one
in six women in the United States reported having taken
a herbal supplement in 2000 [4].
Motivations for CM use among women are little under-
stood. However CM use during pregnancy is driven by
women’s motivations to take an active role in the mainten-
ance of their health [5], a belief in a holistic approach totd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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therapies’ that have fewer side effects [3,5,7,8].
Women view CMs as safe and as at least equally effi-
cacious as medical prescriptions [9,10]. However, safety
concerns arise from the concurrent use of conventional
medical treatment with CM therapy [11] and poor com-
munication about CM consumption between patients
and their health care providers. A lack of disclosure of
CM consumption to conventional health practitioners is
not uncommon [4] and, consequently, interactions with
medications and herbal therapies do occur. In the area
of family planning (FP), which encompasses sexual and
reproductive health, concerns exist for example about an
interaction between St John’s wort (Hypericum perforatum)
with certain hormonal contraceptives [12]. Case reports
of oral contraceptive (OC) failure coinciding with use of
St John’s wort are on record and some studies have
identified potential interactions [13,14]. A pilot study
evaluating the effect of St John’s wort on OC therapy
brought to light a link between the resulting increased
metabolism of norethindrone and ethinylestradiol, and
the occurrence of breakthrough bleeding, follicular growth,
and ovulation [15]. These findings suggest St John’s wort
may reduce the effectiveness of hormonal contraceptives,
with the exception of depot medroxyprogesterone acetate
injections and the levonorgestrel releasing-intrauterine
system, whose efficacy does not appear to be impaired by
the enhancement of the steroid metabolism in the liver.
These findings are reflected in internationally recognised
guidelines for the safe and effective provision of contra-
ceptive methods [16].
Although, according to the literature, women in Australia
are frequent users of CMs [2,3,5], few studies have exam-
ined their utilisation by women attending a FP service.
Understanding women’s use and extent of CM utilisa-
tion, patterns and motivations for use, and disclosure
of CM in this clinical setting is important with assisting
health care providers to promote safe and effective contra-
ception. The aim of this study was to examine (i) the ex-
tent of and type of CM, (ii) women’s views about safety
and efficacy, and (iii) the factors influencing women’s
decision-making.
Methods
We undertook a cross-sectional survey of women at-
tending the main metropolitan urban Family Planning
New South Wales (FPNSW) clinic at Ashfield in Sydney.
Ethics approval was obtained from the Family Planning
New South Wales Ethics Committee. Women were eli-
gible to participate if they were 18 years of age or older,
and were able to read and write English. Eligibility was
confirmed from clinical notes.
An anonymous self-administered questionnaire was
designed to examine previous use of CM (defined as usein the previous 12 months), and women’s current use
(defined as at present and ongoing) their attitudes to-
wards safety and effectiveness, the factors influencing
their decision-making, and their disclosure of CM use to
a FP health professional, women attending for the first
time were asked not to answer this question. Demo-
graphic questions were designed to describe the diversity
of the participants including age, education, country of
birth and languages spoken at home. Questions about
CM use were taken from a previously published survey
[10]. This questionnaire included a broad and inclusive
definition of CM medicines and therapies, and distin-
guished between vitamins and mineral supplements pre-
scribed or not prescribed by a doctor. This distinction
reflects the regulatory framework in Australia where
complementary medicines are regulated as medicines under
the Therapeutic Goods Act1989 [17]. A review of other
surveys was also undertaken and included those previ-
ously used by the author (CS) [5,18,19]. Consultations
were also held with the medical and research directors
and the research team at FPNSW to discuss content and fi-
nalise the design. CM treatments included herbal medi-
cines, vitamin and mineral supplements, other nutritional
supplements, traditional medicines such as traditional
Chinese medicines, homoeopathic medicines, and aroma-
therapy oils (where they make therapeutic claims).
The questionnaire was piloted on ten women attending
the clinic in early January 2011. After these interviews it
was apparent that minor modifications to the wording
of some questions were required. We did not undertake
a power calculation for the sample size; instead we de-
cided to survey all women attending the clinic who met
the eligibility criteria during a two-week period in January,
2011. It was considered that this time period would gener-
ate a population that would be representative of the total
population. All clinic sessions were attended by the re-
search assistant. Women were approached by a research
assistant and invited to participate in the survey. Women
were informed that their participation was voluntary. Only
verbal consent was obtained as completion of the self-
administered questionnaire by women before or after
their consultation confirmed consent.
Statistical analyses were carried out using SPSS soft-
ware (the IBM Statistical Package for the Social Sciences
19, Chicago, IL). Descriptive statistics, using frequencies
and percentages were calculated for demographic and
categorical data, and chi-squared tests were undertaken
to compare CM patterns of use with socio-demographic
characteristics. We subsequently ran logistic regression
models to examine the association between CM use,
attitudinal data and demographics. For the nominal re-
gression model attitude (dependent vaiable) was re-coded
to three categories; agree, disagree and don’t know. The
co-variants included age and education, and education
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adjusted odds ratios and a 95% confidence interval. The
conventional 0.05 level of significance was used to test
for statistical differences.
Results
Between 11 January and 24 January 2011, 221 question-
naires were distributed to eligible women. Of this con-
venience sample, 209 who agreed to participate in the
study completed the questionnaire (94% response rate).
Twelve women declined. The sample represented a varied
population which spanned all eligible reproductive age
groups (Table 1). The majority of women were tertiary
educated. Most were born in Australia but other nation-
alities were well represented, with women born in 33
other countries, who between them spoke 11 languages
other than English at home. Comparing the characteris-
tics of our study population with the profile of clients
attending the Ashfield Clinic at FPNSW, we found our
sample had a similar age profile and country of birth to
the women attending the Ashfield clinic, however ourTable 1 Characteristics of women participating in the survey
Women participating in the survey (n = 20
n % (95% CI)
Age
18–24 years 43 20.5 (15.3-26.7)
25–34 years 56 26.7 (20.9-33.3)
35–44 years 48 22.9 (17.4-29.2)
45 + years 54 25.8 (20.0-32.3)
Missing data 8 3.8 (1.6-7.4)
Highest level of education
Did not finish high-school 8 3.8 (1.6-7.4)
Finished high-school* 32 15.3 (10.7-20.9)
TAFE or similar# 52 24.8 (19.1-31.3)
University degree 108 51.6 (44.6-58.6)
Missing data 9 4.3 (1.9-8.0)
Country of birth
Australia 130 62.2 (55.2-68.8)
United Kingdom 9 4.3 (1.9-8.0)
New Zealand 6 2.8 (1.0-6.1)
China 6 2.8 (1.0-6.1)
Other 49 23.4 (17.8-29.7)
Missing data 9 4.3 (1.9-8.0)
Language spoken at home
English 183 87.5 (82.3-91.7)
Other 18 8.6 (5.1-13.2)
Missing data 8 3.8 (1.6-7.4)
*Finished high school only; #TAFE, Technical and further education institute.
Due to rounding not all percentages add up to 100%.study population was represented by a greater proportion
of women who spoke only English at home (p = 0.01), and
whose education profile differed (p < 0.01). Ashfield is
one of the most culturally diverse communities in inner
Sydney with 43% of the population born overseas.
Patterns of CM use
Eighty-three percent (95% CI 78.0-88.4) of women reported
they had used CM products within the previous 12 months,
and 67% (95% CI 60.6-73.7) of the sample indicated they
were currently using CM products (Table 2). The most
popular CM products included vitamins and minerals.
Consultations with complementary therapists in the previ-
ous 12 months were common, with 70 (33%), 95% CI
27.1-40.3) women reporting visits; a smaller number of
women were currently seeing a CM practitioner (Table 2).
The majority of women consulted with a CM practitioner
or took CMs to maintain their general health, for preven-
tion or to support their immune system, for instance to
prevent a cold (Table 3). The most common specific health
condition treated by CM related to depression and anxiety.and women attending the clinic
9) All women attending Ashfield clinic in 2011 (n = 6242) p-value
n % (95% CI)




1850 29.6 (28.5-30.7) p < 0.001
1368 21.9 (20.9-22.9)
2962 47.4 (46.2-48.7)





5297 84.8 (83.9-85.7) p = 0.014
945 15.1 (14.2-16.0)
Table 2 Use of complementary medicine and therapies (CM) by women




n % (95% CI) n % (95% CI)
Any use of CM 175 83.7 (78.0-88.4) 141 67.4 (60.6-73.7)
Vitamins not prescribed by a doctor 117 55.9 (48.9-62.8) 79 37.8 (31.2-44.7)
Vitamins prescribed by a doctor 32 15.3 (10.7-20.9) 20 9.5 (5.9-14.3)
Mineral supplements not prescribed by a doctor (e.g., zinc, calcium, selenium) 73 34.9 (28.4-41.8) 50 23.9 (18.3-30.2)
Mineral supplements prescribed by a doctor (e.g., zinc, calcium, selenium) 36 17.2 (12.3-23.0) 11 5.2 (2.6-9.2)
Other natural medicines from fish or animals (e.g., fish oils) 73 34.9 (28.4-41.8) 40 19.1 (14.0-25.1)
Herbal teas for health reasons (e.g., valerian, peppermint) 72 34,4 (28.0-41.3) 45 21.5 (16.1-27.7)
Other herbal medicine (e.g., evening primrose oil, black cohosh) 40 19.1 (14.0-25.1) 19 9.0 (5.5-13.8)
Chinese traditional medicines (e.g., Chinese herbs) 22 10.5 (6.7-15.5) 9 4.3 (1.9-8.0)
Aromatherapy oils for medicinal purposes 22 10.5 (6.7-15.5) 7 3.3 (1.3-6.7)
Homoeopathic medicines 15 7.1 (4.0-11.5) 8 3.8 (1.6-7.4)







Any consultation 70 33.5 (27.1-40.3) 39 18.6 (13.6-24.6)
Chiropractor 26 12.4 (8.2-17.6) 12 5.7 (3.0-9.8)
Acupuncturist 23 11.0 (7.0-16.1) 8 3.8 (1.6-7.4)
Naturopath 20 9.5 (5.9-14.3) 8 3.8 (1.6-7.4)
TCM practitioner 14 6.7 (3.7-10.9) 5 2.3 (0.7-5.4)
Osteopath 12 5.7 (3.0-9.8) 7 3.3 (1.3-6.7)
Other (e.g., reflexologist) 21 10.0 (6.3-14.9) 11 5.2 (2.6-9.2)
Categories are not mutually exclusive; women may have been using more than one product/modality. CI confidence interval, TCM traditional Chinese medicine.
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included: no need (n = 27), cost (n = 17), doctor or nurse
has not recommended it (n = 5), lack of information
about therapies available (n = 4), lack of information
about safety (n = 3), or no interest (n = 1).Table 3 Current and previous complementary medicine (CM)
Area of health n = 209
General health (e.g., to stay healthy)








Others (e.g., back pain, neck pain, stress, digestion, cramps, cystitis, subfertility
Categories are not mutually exclusive; women may have been using CM for more t
CI, confidence interval.Our logistic regression analysis show a significant rela-
tionship between young women reporting less previous
use (OR 0.23, 95% CI 0.07-0.72, p = 0.01) and current CM
use (OR 0.24, 95% 0.09-0.61, p = 0.03). We also found that
those not completing high school education were lessuse by health condition
Use in previous 12 months Current use
n % (95% CI) n % (95% CI)
72 34.4 (28.0-41.3) 61 29.1 (23.2-35.8)
36 17.2 (12.3-23.0) 18 8.6 (5.1-13.2)
29 13.8 (9.4-19.3) 18 8.6 (5.1-13.2)
21 10.0 (6.3-15.1) 14 6.7 (3.7-10.9)
14 6.7 (3.7-10.9) 8 3.8 (1.60-7.4)
16 7.6 (4.4-12.1) 7 3.3 (1.3-7.6)
13 6.2 (3.3-10.6) 10 4.7 (2.3-8.6)
12 5.7 (3.0-9.8) 6 2.8 (1.0-6.1)
10 4.7 (2.3-8.6) 8 3.8 (1.6-7.4)
, arthritis) 63 30.1 (24.0-36.8) 31 14.8 (10.3-20.3)
han one area of their health.
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found no relationship between CM use and the language
spoken at home (Table 4).
Attitudes towards safety and effectiveness of CM
Women’s responses about the safety of CM indicate that
many may lack information to make an informed response
to these statements; a third of them selected a ‘don’t know’
answer (Table 5).
Using a multinominal logistic regression we explored
the association between attitudes towards safety and ef-
fectiveness (dependent variables), and age and education
(covariants). Based on our findings in Table 4 the demo-
graphics of age and education were selected to examine
if they would predict the direction of women’s attitudes.
We found no significant individual effects of age and
education on attitudes (Table 6).
Views about CM and reasons for use
Forty-nine percent of women considered CM as being a
‘more natural’ benefit. Less frequently mentioned advan-
tages of CM utilisation included ‘better than taking drugs’
(44%), ‘can complement existing health care’ (40%), ‘effect-
ive, seems to work’ (38%), ‘offers a form of self-care’ (36%),
‘has a focus on prevention’ (35%), ‘a lack of side effects’
(29%), and ‘is perceived to be safe’ (21%). The disadvan-
tages of CMs were viewed as being ‘expensive’ (37%),
‘a lack of research on how it works’ (28%), and ‘uncertain
if it will work’ (26%).
Information and communication
Information on CM was mainly obtained from family





18-24 0.23 (0.07, 0.7
25-34 0.85 (0.24, 2.9
35-44 0.51 (0.15, 1.6
45+ referen
Model 2: Education
Did not finish high school 0.39 (0.15, 1.0
Finished high school 0.68 (0.74, 6.3
TAFE or similar 0.65 (0.26, 1.6
University degree referen
Model 3: Language spoken at home
English 1.5 (0.48, 5.1
Other referen
OR Odds Ratio, CI confidence interval, TAFE Technical and further education institut(books and magazines 49%), health professionals (38%),
and CM practitioners (25%).
Women who had used CM in the previous 12 months
were asked if they discussed their self prescribing use of
CM or consultation with a CM practitioner during their
FP consultation. Forty-four percent of participants had;
those who had not indicated that they considered CM
unrelated to consultation at FPNSW (43%), did not view
CM as a medicine (30%) or were worried about discussing
this with their doctor or nurse (5%). Two women ex-
plained in an open response that they had not mentioned
it because they were not asked.
Discussion
Over 80% of women attending the metropolitan Family
Planning New South Wales (FPNSW) clinic at Ashfield
we surveyed had visited a CM practitioner or used CMs
in the previous 12 months, and two thirds were currently
using CMs. Our study highlights the popularity of dietary
supplements, including vitamins and minerals, and con-
sultation with chiropractors and acupuncturists. This
population reported using CM for health maintenance
and self care. The advantages of CMs identified by par-
ticipants included enhanced self-care, perceived safety,
and being ‘natural’. Most participants did not mention
their CM use because they considered this information
irrelevant to their clinical consultation (rather than out
of a fear of rejection); because they had not been asked;
or because this information had been dismissed after
disclosure.
Although the prevalence of CM use we recorded was
slightly higher than that (74.4%, 95% CI 70.7–78.1)
reported in the last national survey undertaken in Australiag women by demographic variables
Dependent variables
M use Current CM use
) p-value OR (95% CI) p-value
2) 0.01 0.24 (0.09, 0.61) 0.03
6) 0.79 0.52 (0.20, 1.31) 0.16
8) 0.26 0.34 (0.13, 0.88) 0.02
ce reference
2) 0.05 0.44 (0.20, 1.00) 0.05
2) 0.73 0.70 (0.12, 4.08) 0.70
4) 0.36 0.66 (0.32, 1.36) 0.27
ce reference
5) 0.44 1.08 (0.38, 3.04) 0.87
ce reference
e.
Table 5 Survey participants’ beliefs and views about complementary medicines
n = 209 Strongly
disagree
Disagree Agree Strongly agree Don’t know
n % 95% CI n % 95% CI n % 95% CI n % 95% CI n % 95% CI
I only use
CM as a last resort 42 20.1 14.8-26.1 84 40.1 33.4-47.1 25 11.9 7.8-17.1 2 0.9 0.12-3.4 45 21.5 16.1-27.7
CMs are not as risky as prescribed medication 11 5.2 2.6-9.2 62 29.6 23.5-36.3 67 32.0 25.7-38.8 17 8.1 4.8-12.7 37 17.7 12.7-23.5
CMs can cause dangerous side effects 19 9.0 5.5-13.8 60 28.7 22.6-35.3 45 21.3 16.1-27.7 9 4.3 1.9-8.0 61 29.1 23.1-35.8
Ingredients in CM make them safe to use 11 5.2 2.6-9.2 40 19.1 14.0-25.1 68 32.5 26.2-39.3 7 3.3 1.3-6.7 69 33.0 26.6-39.8
Percentages may not add up to 100% due to rounding.
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among pregnant Australian women [3]. A cohort study has
shown that women who consulted with CM practitioners
had increased over time, with 9%, 16%, 21% and 33% of
women consulting a CM practitioner in 1996, 2000, 2003,
and 2006, respectively [3] The slightly higher rate of CM
utilisation in our study may be explained by the fact that
women attending a FP service may be more likely to use
CM for self care or consult with practitioners, or our defin-
ition of CMs.
Women accessed information on CMs most frequently
from non-medical sources including the internet, family
and friends. These findings are supported by other studies
from different clinical populations [20]. Forty-four per-
cent of clients mentioned their consultations and self-
prescribed use of CM to their healthcare provider. There
are no reported studies of a general clinic population with
which to compare our findings. However a study of preg-
nant women in the USA suggests similar levels of non-
disclosure (52%) to health care providers [21].
We have shown that many women combine conven-
tional health care with self-administered CM and consul-
tations with CM practitioners. The findings also highlight
that some women have limited awareness of the import-
ance of disclosing CM use to the practitioner in the FP
unit. This finding is important because the latter may,
therefore, not receive full information to include in the
clinical history of the patient or become aware of a poten-
tial interaction between prescribed medications and CM
remedies.
The survey had a response rate of 94%, reducing the
potential for a response-bias. Also the opportunity for
measurement error was reduced by (i) piloting of the
questionnaire, (ii) revising the instrument prior to imple-
mentation of the study, and (iii) having a researcher on
site to assist with enquiries.
However, there are limitations to the study. Respon-
dents were self-selected rather than randomly chosen,
and therefore may not be representative of the clinic
population as a whole. In fact we know that the sample
was not representative of the larger clinic population
with regard to two socio-demographic characteristics,significantly more women in the sample spoke English at
home, and had a different level of education attainment
than the FPNSW clinic population. Compared with na-
tional socio-demographic data the FPNSW clinic popula-
tion has a slightly higher (5%) overseas born population,
with a higher preference for other languages at home
(5%). Our sample maybe more comparable to all family
planning organisations in Australia. In addition, because
we undertook a snapshot of clinic attendees during a
two-week period, bias may have been introduced if there
were groups of women who did not attend at this time
of the year.
The questionnaire included CM modalities reporting a
therapeutic claim. Our criteria may have led to some
modalities being excluded, and consequently to the find-
ing of a lower rate of utilisation than would otherwise
have been the case. There is no widely accepted oper-
ational definition of CM. Wiedland [22] and colleagues
report on an operational definition for CM therapies
based on (i) therapies that rely upon non-allopathic models
of health, (ii) exclusion from standard treatment within
the dominant medical system, and (iii) self-care or care
delivered by alternative practitioners. A lack of efficacy
was not a criterion for identifying CM. If we had adopted
the definition of CM described by Wiedland and co-
authors’, the reporting of CM use in our survey would
likely to have increased. Despite these limitations, the
similarities of our findings with national surveys support
the validity of the study. Our results indicate that CM is
widely used by women attending a FP service at an
inner city clinic in Sydney.
Despite the increased awareness from research on the
importance of health care providers discussing CM use
with their patients, we highlight our findings in the
context of a gap in knowledge in this clinical setting.
Our findings also have implications for international FP
programmes where use of traditional medicines (trad-
itional Chinese medicine, Indian Ayurveda, and practices
that include herbal medicines) are prevalent [23]. Women
need to be informed that communication about use of
CMs is relevant and important. Providing information and
education to clinicians about what CMs are available and
Table 6 Multinominal regression of participants’ beliefs
and views about complementary medicines by
demographic variables
n = 209 OR 95% CI
I only use CM as a last resorta
Disagree















CMs are not as risky as prescribed medication
Disagree















CMs can cause dangerous side effects
Disagree







Table 6 Multinominal regression of participants’ beliefs
and views about complementary medicines by
demographic variables (Continued)
Don’t know







Ingredients in CM make them safe to use
Disagree















the reference category is agree.
b this parameter is set to zero because it is redundant.
OR, Odds Ratio, CI, confidence interval; CM complementary medicine.
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respect for women’s use of CMs. The study has drawn at-
tention to non disclosure of CM in this clinic and the need
for clinicians to be further informed about the potential
for herb-drug interactions, and to be more proactive with
seeking information about CM use, particularly among
women using oral contraceptives. In our study 16 women
reported use of St Johns wort in the previous 12 months,
and six women were currently using this herb for anxiety
of depression. Due to the anonymous nature of the ques-
tionnaire we do not know if these women were using oral
contraceptives, however these is the possibility of potential
a herb-drug interaction arising for some women. Further
discussion about CMs may also have a positive impact on
satisfaction with the consultation as clients may feel they
are being listened to and that their healthcare providers
are interested in their personal situation.
A large number of women appear to be uninformed
about the safety of CM. We did not explore the reasons
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of CM, and this appears to be an under-researched area.
Future research using qualitative designs would contrib-
ute valuable information to assist the development of
appropriate communication strategies.
Conclusion
We have demonstrated in our study the high frequency
of CM utilisation for self-care among women attending
an Australian FP clinic, however our findings may not be
generalisable to all groups of women attending this clinic.
We also identified a notable gap in women’s awareness of
the risks and benefits of CM, the potential for interactions
between CM and prescribed medication, and the import-
ance of disclosure and communication of their consulta-
tions with CM practitioners. Other healthcare providers
(e.g., family physicians) who may interact with this group
of women should be aware of the widespread and fre-
quent use of CM. Our findings also emphasise the need
for healthcare providers to initiate discussions with clients
about their utilisation of CM.
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